IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
 

Search About Journals, Conferences, and Book Series


EMBO Molecular Medicine- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

10.72

h-Index

 119

Rank

 379

SJR

 4.039

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title EMBO Molecular Medicine
Abbreviation EMBO Mol. Med.
Publication Type Journal
Subject Area, Categories, Scope Molecular Medicine (Q1)
h-index 119
Overall Rank/Ranking 379
SCImago Journal Rank (SJR) 4.039
Impact Score 10.72
Publisher Wiley-Blackwell
Country United Kingdom
ISSN 17574676, 17574684




About EMBO Molecular Medicine


EMBO Molecular Medicine is a journal covering the technologies/fields/categories related to Molecular Medicine (Q1). It is published by Wiley-Blackwell. The overall rank of EMBO Molecular Medicine is 379. According to SCImago Journal Rank (SJR), this journal is ranked 4.039. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 119. The best quartile for this journal is Q1.

The ISSN of EMBO Molecular Medicine journal is 17574676, 17574684. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. EMBO Molecular Medicine is cited by a total of 3946 articles during the last 3 years (Preceding 2021).




EMBO Molecular Medicine Impact Score 2021-2022


The impact score (IS) 2021 of EMBO Molecular Medicine is 10.72, which is computed in 2022 as per its definition. EMBO Molecular Medicine IS is increased by a factor of 1.8 and approximate percentage change is 20.18% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

EMBO Molecular Medicine Impact Score 2022 Prediction


IS 2021 of EMBO Molecular Medicine is 10.72. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of EMBO Molecular Medicine. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 10.72
2020 8.92
2019 7.17
2018 9.09
2017 9.21
2016 8.38
2015 8.77
2014 7.74

EMBO Molecular Medicine h-index


  Table Setting

EMBO Molecular Medicine has an h-index of 119. It means 119 articles of this journal have more than 119 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




EMBO Molecular Medicine ISSN


The ISSN of EMBO Molecular Medicine is 17574676, 17574684. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

EMBO Molecular Medicine Rank and SCImago Journal Rank (SJR)


The overall rank of EMBO Molecular Medicine is 379. According to SCImago Journal Rank (SJR), this journal is ranked 4.039. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


EMBO Molecular Medicine Publisher


Table Setting

EMBO Molecular Medicine is published by Wiley-Blackwell. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2009-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of EMBO Molecular Medicine is EMBO Mol. Med.. This abbreviation ('EMBO Mol. Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in EMBO Molecular Medicine


If your research field is/are related to Molecular Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Meteorologica journal 22667 Centro Argentino de Meteorologos 4 0.40
Molecular Pharmaceutics journal 4509 American Chemical Society 138 5.19
Quaderni Urbinati di Cultura Classica journal 26305 Fabrizio Serra Editore srl 6 0.08
Revista Latinoamericana de Derecho Social journal 25025 Universidad Nacional Autonoma de Mexico 4 0.14
Indiana Law Journal journal 14539 Indiana University 29 0.56
International Journal of Psychiatry in Medicine journal 13305 SAGE Publications Inc. 57 1.10
International Journal of Computer Network and Information Security journal 11229 Modern Education and Computer Science Press 4 2.30
Queen Mary Journal of Intellectual Property journal 24070 Edward Elgar Publishing Ltd. 7 0.16
Science of Soil and Water Conservation journal 19376 6 0.54
Asia Pacific Journal of Tourism Research journal 4900 Taylor and Francis Ltd. 44 4.04

Check complete list



Jasper


Year wise Impact Score (IS) of EMBO Molecular Medicine

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 10.72
2020 8.92
2019 7.17
2018 9.09
2017 9.21
2016 8.38
2015 8.77
2014 7.74



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Genome Medicine
BioMed Central Ltd. | United Kingdom

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Cell Chemical Biology
Elsevier Inc. | United States

See All